Background Faecal microbiota transplantation (FMT) is effective for recurrent Clostridioides
difficile infection (CDI), but inconsistent effect rates and uncertain evidence levels have …

Background Clostridium difficile infection (CDI) is the commonest nosocomial cause of
diarrhoea. Faecal microbiota transplantation (FMT) is an approved treatment for recurrent or …

Faecal microbiota transplantation (FMT) is an important therapeutic option for Clostridium
difficile infection. Promising findings suggest that FMT may play a role also in the …

Fecal microbiota transplantation (FMT) has become a highly effective bacteriotherapy for
recurrent Clostridium difficile infection. Meanwhile the efficacy of FMT for treating chronic …

Interest in the therapeutic potential of faecal microbiota transplant (FMT) has been
increasing globally in recent years, particularly as a result of randomised studies in which it …

Importance Clostridium difficileinfection (CDI) is a major burden in health care and
community settings. CDI recurrence is of particular concern because of limited treatment …

This Review summarizes mechanistic investigations in faecal microbiota transplantation
(FMT), which has increasingly been adapted into clinical practice as treatment for …

Background Fecal microbiota transplantation (FMT) is a microbiota-based therapy that
shows therapeutic potential in recurrent or refractory Clostridium difficile infections and other …

The community of microorganisms within the human gut (or microbiota) is critical to health
and functions with a level of complexity comparable to that of an organ system. Alterations of …

Considerable evidence points to the critical role of the gut microbiota in physiology and
disease. The administration of live microbes as a therapeutic modality is increasingly being …